Navigation Links
Codexis Names Wes Bolsen VP and Chief Marketing Officer
Date:12/5/2011

REDWOOD CITY, Calif., Dec. 5, 2011 /PRNewswire/ -- Codexis, Inc. (Nasdaq: CDXS) today announced Wesley J. Bolsen has been named Vice President and Chief Marketing Officer.  In this new position, Mr. Bolsen will have responsibility for the company's corporate marketing and communications.  He will report to Alan Shaw, Ph.D., President and Chief Executive Officer.

Mr. Bolsen is a widely recognized marketing executive in the global biofuels industry. He joins Codexis from Coskata, where he most recently served as Chief Marketing Officer. While at Coskata from 2007-2011, he also held the senior management positions of Vice President, Government Affairs and Vice President, Business Development.  Previously, he was Chief Financial Officer for ICM, Inc., and a Senior Consultant for McKinsey & Co.

He was named the Top CMO in the United States in 2011 by the Chief Marketing Officer Institute, and is an executive board member of the Renewable Fuels Association, a former board member of the Advanced Biofuels Association and a founding member of the Advanced Ethanol Council. Mr. Bolsen holds a bachelor's degree in electrical engineering from Rose Hulman Institute of Technology and an MBA from the Stanford Graduate School of Business.

"We are very pleased to welcome Wes Bolsen to Codexis," Dr. Shaw said.  "His active leadership role as an advocate in the biofuels industry, combined with his proven expertise in marketing, will be important as Codexis moves towards commercialization of renewable fuels and chemicals products."

Codexis is an industrial biotechnology company producing high value sustainable chemicals, clean fuels, cost effective pharmaceutical processes and renewable bioindustrial ingredients to make industry more efficient, productive and profitable.  Partners include global leaders such as Shell, Merck and Pfizer.  For more information, see www.codexis.com.

 

Contacts:
Media:  Lyn Christenson, lyn.christenson@codexis.com, 650.421.8144 or Saskia Sidenfaden, ssidenfaden@mww.com, 212.827.3771; Investors:  Henk Adriaenssens, ir@codexis.com, 650.421.8331

 


'/>"/>
SOURCE Codexis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Shell Transfers Its Codexis Shares to Raizen
2. Codexis Reports First Quarter 2011 Results
3. Former Senator Byron Dorgan Elected to Codexis Board
4. Codexis Reports Fourth Quarter and Full Year 2010 Results
5. Codexis Grows Revenue 35 Percent in Third Quarter; Raises 2010 Outlook
6. Codexis Names Vonnie Estes to New Technology Strategic Planning VP Role
7. Codexis R&D Productivity Panels Also Used By Roche
8. Codexis Names Lori Giver VP Systems Biology
9. Codexis, Teva in Licensing Agreement Final
10. Codexis Names Vice President, Intellectual Property
11. Codexis, Arch Announce Expanded Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):